<p>The current infecting serotype, previous infecting serotype(s) and “non-exposed serotypes” were determined as described in <a href="http://www.plosntds.org/article/info:doi/10.1371/journal.pntd.0002451#s2" target="_blank">Methods</a>. [anti-FL Abs] and NT<sub>50</sub> against the current infecting serotype (A, E) and “non-exposed” serotypes (B to D, F to H) in patients with secondary DENV3 (A to D) and secondary DENV2 (E to H) infections.</p
<p>(<b>A</b>) IFN-competent A549 cells were treated with 100 IU/ml IFN-α prior to (-4 h, -2 h) or af...
<p>A) Neutralisation and ADE of all four DENV serotypes, ZIKV, WNV and YFV, with DENV anti-3DI/DII a...
Although heterotypic secondary infection with dengue virus (DENV) is associated with severe disease,...
<p><b>A.</b> DENV-specific neutralization of the serum at 3 months post-onset of symptoms in 2° DENV...
a<p>Primary or secondary DENV infection was determined as described in <a href="http://www.plosntds....
<p>*Primary or secondary infection was determined by PRNT<sub>50</sub> as described in Methods.</p><...
<p><b>A.</b> DENV3-specific NT<sub>50</sub> of serum day 4–6 (acute), day 14–28 (convalescent), 3 m,...
*<p>Serotype confirmation was performed on 150 of 1297 total participants.</p>**<p>Only analyzed fat...
<p>Sixty serum samples exhibiting neutralizing activity to DENV were analyzed for presence of infect...
<p>(<b>A</b>) Plaque reduction and neutralization curves for five DENV-1 strains representing the fi...
<p>Each row shows one PCR positive (“susceptible”) subject and two matched PCR negative (“non-suscep...
A: Ex vivo ELISpot responses to DENV NS1, NS3, NS5 and combined DENV-ALL overlapping peptides in pat...
a<p>Infecting serotype indicates the DENV serotype detected in the serum sample as determined by RT-...
<p>The percent of dengue cases infected by each DENV serotype, of the total infections with known se...
<p>(A) [anti-E Abs] and (B) [anti-FL Abs] in samples collected 3, 6, 12 and 18 months post-infection...
<p>(<b>A</b>) IFN-competent A549 cells were treated with 100 IU/ml IFN-α prior to (-4 h, -2 h) or af...
<p>A) Neutralisation and ADE of all four DENV serotypes, ZIKV, WNV and YFV, with DENV anti-3DI/DII a...
Although heterotypic secondary infection with dengue virus (DENV) is associated with severe disease,...
<p><b>A.</b> DENV-specific neutralization of the serum at 3 months post-onset of symptoms in 2° DENV...
a<p>Primary or secondary DENV infection was determined as described in <a href="http://www.plosntds....
<p>*Primary or secondary infection was determined by PRNT<sub>50</sub> as described in Methods.</p><...
<p><b>A.</b> DENV3-specific NT<sub>50</sub> of serum day 4–6 (acute), day 14–28 (convalescent), 3 m,...
*<p>Serotype confirmation was performed on 150 of 1297 total participants.</p>**<p>Only analyzed fat...
<p>Sixty serum samples exhibiting neutralizing activity to DENV were analyzed for presence of infect...
<p>(<b>A</b>) Plaque reduction and neutralization curves for five DENV-1 strains representing the fi...
<p>Each row shows one PCR positive (“susceptible”) subject and two matched PCR negative (“non-suscep...
A: Ex vivo ELISpot responses to DENV NS1, NS3, NS5 and combined DENV-ALL overlapping peptides in pat...
a<p>Infecting serotype indicates the DENV serotype detected in the serum sample as determined by RT-...
<p>The percent of dengue cases infected by each DENV serotype, of the total infections with known se...
<p>(A) [anti-E Abs] and (B) [anti-FL Abs] in samples collected 3, 6, 12 and 18 months post-infection...
<p>(<b>A</b>) IFN-competent A549 cells were treated with 100 IU/ml IFN-α prior to (-4 h, -2 h) or af...
<p>A) Neutralisation and ADE of all four DENV serotypes, ZIKV, WNV and YFV, with DENV anti-3DI/DII a...
Although heterotypic secondary infection with dengue virus (DENV) is associated with severe disease,...